---
title: Esco Aster vs uBriGene
slug_a: escoaster
slug_b: ubrigene
site: cdmo
review_signal_gate: closed
canonical_path: /compare/escoaster/ubrigene
generated_by: BioBM Editorial AI
---

# Esco Aster vs uBriGene

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Esco Aster (escoaster) is listed for both. Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.

Services: 5. Modalities: 4. Indications: 4. Locations: 0. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

uBriGene (ubrigene) is listed for both. uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.